News

The study was conducted by the Southwest Oncology Group (SWOG), a cancer center network sponsored by the National Cancer Institute. SWOG will engage with ImClone and Bristol-Myers Squibb

Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. If acquired, the license from Isis would include rights to

<p>The new facility, Abbott Biotechnology Limited (ABL), received FDA approval in February to commercially produce Humira for the US market. The new plant is Abbott&#0039;s single-largest capital investment

<p>The notice referred to the patents that cover the method of use and formulation of Endo&#0039;s lidocaine-containing topical patch products, Lidoderm and Synera. <br /><br />If approved, Endo

The agreement includes Transgene’s lead therapeutic vaccine candidate TG 4001, currently in clinical development to treat neoplasia, a precancerous cervical abnormality which can lead to cervical cancer. Under

Davanat is co-administered with 5-Fluorouracil (5-FU) to treat cancer patients. 5-FU is an FDA-approved chemotherapy drug that is used to treat various types of cancers, including colorectal, breast

Johnson & Johnson said the voluntary recall is a precaution based on two reports of glass fragments found in bottles of the liquid formulation. The voluntary recall is

This extension provides Renovis with additional research funding through to June 2008 and reflects the goal of Pfizer and Renovis to advance multiple, small molecule VR1 antagonists toward

This phase II study is designed to evaluate the safety and efficacy of the eye drop, ATG3, in patients with age-related macular degeneration (AMD). All patients will be